The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Shelly Kumar
RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of respiratory disorders, including sleep apnea, opioid-induced respiratory depression, and respiratory insufficiency due to spinal cord injury, announces that the Company’s Chief Executive Officer and Vice Chairman of the Board of Directors, James
IntelGenx shared the decision placed by the Delaware Court in which the process used to manufacture an opiate addiction treatment does not infringe the patent of MonoSol Rx.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
Achieve Life Sciences completed its merger with OncoGenex Pharmaceuticals.
As part of a wide attempt to decrease the impact of opioid abuse, a healthcare company’s novel treatment of alcohol and opioids addiction will be used in three EnLite Clinics in Ohio.
From Uruguay’s full legalization to the debate between regional leaders in Canada questioning the recreational deadline, and a variety of market news INN provides a roundup of the week in cannabis
By Shelly Kumar
Benjamin Ward, CEO of Maricann Group Inc., a vertically-integrated greenhouse producer and distributor of medical cannabis. Toronto, Canada-based Maricann is now building global teams in rapidly expanding European markets as well.
As quoted in the article:
“European markets are increasingly important to the cannabis sector. Each has a well-funded medical system, residents who
By Micha Boon
Benjamin Ward, CEO of Maricann Group Inc (CSE:MARI) has recently commented on some of the changes within the cannabis industry. Some of these changes are stemming from Canada’s upcoming legalization and a changing of attitudes.
There is a global shift in cannabis towards Western Europe.
That’s where the action in